David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$510M |
| 2 |
Bank of America
BAC
|
+$395M |
| 3 |
Meta Platforms (Facebook)
META
|
+$365M |
| 4 |
Costco
COST
|
+$351M |
| 5 |
Procter & Gamble
PG
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$573M |
| 2 |
Advanced Micro Devices
AMD
|
+$405M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$387M |
| 4 |
Walmart Inc
WMT
|
+$364M |
| 5 |
Amazon
AMZN
|
+$358M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.38% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 7.82% |
| 4 | Consumer Discretionary | 7.11% |
| 5 | Communication Services | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
United Therapeutics
UTHR
$22B
| $20.6M | 0.02% |
87,632
-11,684
| -12% | -$2.38M |
|
752
PUT
BioNTech
BNTX
$28.5B
| $20.6M | 0.02% |
138,100
-91,400
| -40% | -$14M |
|
753
Twilio
TWLO
$34.3B
| $20.6M | 0.02% |
245,551
-32,398
| -12% | -$3.62M |
|
754
Novartis
NVS
$300B
| $20.6M | 0.02% |
243,412
-236,477
| -49% | -$20.7M |
|
|
HOUS
755
DELISTED
Anywhere Real Estate
HOUS
| $20.5M | 0.02% |
2,081,252
-551,903
| -21% | -$6.5M |
|
|
DOO
756
Bombardier Recreational Products
DOO
$4.68B
| $20.4M | 0.02% |
332,319
+30,000
| +10% | +$2.24M |
|
757
US Bancorp
USB
$97.3B
| $20.4M | 0.02% |
443,623
+31,114
| +8% | +$1.55M |
|
758
Academy Sports + Outdoors
ASO
$2.87B
| $20.4M | 0.02% |
573,799
-179,958
| -24% | -$6.59M |
|
759
CALL
Adobe
ADBE
$110B
| $20.4M | 0.02% |
55,600
-68,900
| -55% | -$28M |
|
760
RTX Corp
RTX
$282B
| $20.2M | 0.02% |
210,083
-86,122
| -29% | -$8.28M |
|
761
CALL
DexCom
DXCM
$34.6B
| $20.2M | 0.02% |
270,800
-59,200
| -18% | -$5.4M |
|
762
Diageo
DEO
$53.5B
| $20.2M | 0.02% |
115,893
+56,324
| +95% | +$10.7M |
|
763
PUT
Datadog
DDOG
$82B
| $20.2M | 0.02% |
211,600
-68,400
| -24% | -$7.52M |
|
764
Clarus
CLAR
$146M
| $20.1M | 0.02% |
1,059,643
+960,780
| +972% | +$20.1M |
|
765
PUT
MarketAxess Holdings
MKTX
$5.71B
| $20.1M | 0.02% |
78,600
-40,300
| -34% | -$11M |
|
766
Warner Music
WMG
$14.5B
| $20.1M | 0.02% |
824,895
+603,415
| +272% | +$18M |
|
767
Guidewire Software
GWRE
$16.1B
| $20.1M | 0.02% |
283,004
+28,807
| +11% | +$2.36M |
|
768
Campbell Soup
CPB
$7.18B
| $20.1M | 0.02% |
417,470
-239,126
| -36% | -$11.3M |
|
|
MRSH
769
Marsh
MRSH
$92.5B
| $20.1M | 0.02% |
129,151
+86,034
| +200% | +$13.8M |
|
|
TWOU
770
DELISTED
2U Inc
TWOU
| $19.9M | 0.02% |
63,360
+16,269
| +35% | +$5.02M |
|
771
CALL
Teladoc Health
TDOC
$1.14B
| $19.9M | 0.02% |
598,900
+103,900
| +21% | +$4.41M |
|
772
CALL
Diamondback Energy
FANG
$57.3B
| $19.9M | 0.02% |
163,900
-85,700
| -34% | -$11.7M |
|
773
Alnylam Pharmaceuticals
ALNY
$31.6B
| $19.8M | 0.02% |
135,923
+121,040
| +813% | +$17.2M |
|
774
PUT
Sunrun
RUN
$2.16B
| $19.8M | 0.02% |
847,700
-119,500
| -12% | -$2.87M |
|
775
PUT
Cenovus Energy
CVE
$59.6B
| $19.8M | 0.02% |
1,038,700
-676,100
| -39% | -$13.5M |
|
Similar funds
David Shaw's Q2 2022 Portfolio in Review
As of Q2 2022, David Shaw held 6,080 positions worth $85.3B, down 20% from $107B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
David Shaw withdrew a net $8.25B in Q2 2022, closing 791 positions and reducing 1,835 holdings. Its most notable exit was Dominion Energy, Inc. 2019 Series A Corporate Units, an estimated $64.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
Against the trend, David Shaw opened a new position in iShares MSCI Emerging Markets ETF worth $171M.
- David Shaw's largest Q2 2022 buy was iShares MSCI Emerging Markets ETF: 4,273,656 shares worth $171M.
- David Shaw added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $510M increase.
- David Shaw's biggest Q2 2022 reduction was Marathon Petroleum, cutting an estimated $573M.
- David Shaw fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q2 2022, selling an estimated $64.1M.
- David Shaw's ten largest holdings make up 8.5% of its $85.3B portfolio in Q2 2022.
- David Shaw opened 595 new positions and closed 791 in Q2 2022.
- David Shaw's portfolio value fell 20% quarter-over-quarter to $85.3B.
Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.